NDA 021247 · Pharmobedient
Aerospan Hfa
Flunisolide · Inhalation
DiscontinuedLast checked: Nov 20, 2026Latest source record: Apr 25, 2018 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations
First approved
2006
Jan 27, 2006
Approved uses
2
Original approval plus efficacy supplements
Registered trials
5
1 Phase 3, 0 recruiting
FAERS reports
0
0 serious, 0 with death reported
AI brief across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.
What it is approved for
No structured label for this application in openFDA. Older and discontinued products often have none.
Approval history
Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.
- Aug 28, 2013 Supplement 8 · Efficacy LetterLabel
- Jan 27, 2006 Original approval · Type 3 - New Dosage Form ReviewLabelLetter
1 products under this application
- AEROSPAN HFA · FLUNISOLIDE 0.078MG/INH · AEROSOL, METERED, INHALATION · Discontinued
Clinical trials
Interventional ClinicalTrials.gov studies with "Flunisolide" as an intervention, any sponsor and status, largest first.
- Validation Of Preference Module Of Experience With Allergic Rhinitis Nasal Sprays Questionnaire (EARNS-Q)Pivotal-lookingCompleted
GlaxoSmithKlineGSK (GSK)
NCT00346775 · 97 participants · Start May 1, 2006 · Primary completion Jun 29, 2006
Drug: Beclomethasone dipropionate; Flunisolide · For: Rhinitis, Allergic, Perennial
Sites: Fresno, California; Napa, California; Roseville, California · 7 sites in all
Universidad de GranadaAcademic, hospital or other
NCT02515318 · 60 participants (planned) · Start Sep 2015 · Primary completion Mar 2017
Drug: Medical standard treatment · For: COPD
Sites: Granada, Spain · 2 sites in all
University of California, Los AngelesAcademic, hospital or other
NCT00203684 · 57 participants
Drug: Flunisolide-HFA; Flunisolide-CFC · For: Asthma; Distal Lung Inflammation
Sites: Los Angeles, California
Universidad de GranadaAcademic, hospital or other
NCT02509299 · 49 participants · Start Sep 1, 2019 · Primary completion Nov 20, 2019
Drug: Standard medical treatment · For: COPD
Sites: Granada, Spain
University of LouisvilleAcademic, hospital or other
NCT02404103 · 26 participants · Start Mar 2015 · Primary completion May 2017
Drug: Flunisolide HFA · For: Childhood Asthma
Sites: Louisville, Kentucky
Most reported adverse reactions
FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.
No FAERS reports name this application.
FAERS reports by year
By the date FDA received the report.
No reports.
Recalls
0 FDA enforcement reports for this application.
No recalls on record for this application.
Shortages
FDA's drug shortage list.
Not on FDA's shortage list.
Medicare spending
CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.
Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.
Published evidence
PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.
- Flunisolide nasal spray in the treatment of perennial rhinitis.
Horan JD, Johnson JD · Can Med Assoc J 1978 · Clinical Trial, Controlled Clinical Trial
- Comparison of high-dose inhaled flunisolide to systemic corticosteroids in severe adult asthma.
Lee-Wong M, Dayrit FM, Kohli AR, et al. · Chest 2002 · Clinical Trial, Comparative Study
- Epistaxis Risk Associated with Intranasal Corticosteroid Sprays: A Systematic Review and Meta-analysis.
Wu EL, Harris WC, Babcock CM, et al. · Otolaryngol Head Neck Surg 2019 · Meta-Analysis, Research Support, Non-U.S. Gov't
- Intranasal corticosteroids for nasal airway obstruction in children with moderate to severe adenoidal hypertrophy.
Zhang L, Mendoza-Sassi RA, César JA, et al. · Cochrane Database Syst Rev 2008 · Systematic Review
- A randomized controlled trial of inhaled flunisolide in the management of acute asthma in children.
Nakanishi AK, Klasner AK, Rubin BK · Chest 2003 · Clinical Trial, Comparative Study
- A bioassay for topical and systemic effect of three inhaled corticosteroids.
McCubbin MM, Milavetz G, Grandgeorge S, et al. · Clin Pharmacol Ther 1995 · Clinical Trial, Comparative Study
Sponsor: Pharmobedient
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.